Emerson Electric Company (EMR) Dividend Safety Gauge & 10-Year DRIP Compounder

$164.94 -3.40% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $163.62

Emerson Electric Company (EMR) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ β€’ HOLD / WATCH Cap $95.24B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on EMR Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is EMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Emerson Electric Company (NYSE: EMR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $164.94 (-3.40% 1D, market cap $95.24B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, EMR ranks #105 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does EMR compare to GEV and OTIS in the Technology sector?
β–Ό

Within the Technology sector (Consumer Electronics/Appliances), EMR carries a Roarable C+ (69/100 RQD), trailing P/E of 41.5x, gross margin of 52.8%, and ROIC of 9.7%. By comparison, GEV (GE Vernova Inc.) holds a D grade (49/100 RQD, P/E 48.1x, ROIC 4.4%, cap $234.99B) and OTIS (Otis Worldwide Corporation) posts a C grade (65/100 RQD, P/E 20.5x, ROIC 74.2%, cap $28.40B). Among the 5-stock peer group, OTIS leads on earnings multiple (20.5x) while OTIS leads on capital efficiency (74.2% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for EMR?
β–Ό

Per EMR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0000032604), Emerson Electric Company generated $18.02B in revenue (+3.0% YoY), $2.29B in net income, and $2.67B in free cash flow against $41.94B in total assets and $7.58B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $163.62 (-0.80%)🧬 Cannibal Buyback (-0.96% YoY Shares)βš™οΈ Cash Engine: 12/20 (C-) β€’ 14.8% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY β€’ 57.3% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERHOLD / WATCH β€’ C+
025507510069
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ Β· Rk B-
Cash (12)Whales (18)SEC (18)Macro (10)CEO (11)
Each axis scored 0–20
12M PRICE TARGET CONE+4.9% Base Target
$204 Bull$173 Base$135 Bear
πŸ“¬ FREE EMR RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for EMR)Realized 20D OHLCV Swing Band: Β±5.6%
Deterministic 5-Pillar Attribution (69/100 Composite)
πŸ” WHY EMR SCORES 69/100 (C+) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Whale & Options Positioning+18/20 pts (26% of score)

20D Institutional Volume Accumulation (Β±5.6% realized swing band)

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (26% of score)

Altman Z-Score 4.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 7/9

β–Ό #1 Drag / Risk Factor: Macro Regime Fit10/20 pts (-10 pt drag)

Macro rate sensitivity & RSI-14 (64.1) create a -10 pt regime headwind

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
61
Grade C$163.50-1.9% Next Q
Q2 (-2Q)
64
Grade C+$160.46+3.6% Next Q
Q3 (-1Q)
66
Grade B-$166.27-0.8% Next Q
Current
69
Grade C+$164.94+2% Hist 90D Ξ±
Trajectory: C (61) β†’ C+ (69)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the EMR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 69/100 (C+) score, EMR faces multiple-compression risk if 41.5x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Priced at 42x earningsβ€”high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($157.60) or 200D SMA ($147.25) invalidates the momentum regime and cuts Target Base ($173.10) toward Bear Floor ($135.02).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $EMRβ€’ $4.8M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œEMR Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
CASH DIVIDEND + BUYBACK YIELD
3.05% Total Yield
1.25% Cash ($2.06/yr) + 1.8% Buybacks
PAYOUT SAFETY SPEEDOMETER
88/100 β€’ FORTRESS PAYOUT
FREE CASH FLOW PAYOUT RATIO
29% of FCF
8 consecutive years of payout growth
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (6.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years β†’ $18,771

Est. Year-10 Shareholder Yield: $573/yr
$10.7K
Yr 1
$11.3K
Yr 2
$12.1K
Yr 3
$12.9K
Yr 4
$13.7K
Yr 5
$14.6K
Yr 6
$15.5K
Yr 7
$16.5K
Yr 8
$17.6K
Yr 9
$18.8K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in EMR & A-Rated Leaders

  • βœ“12-month Bull/Base/Bear fair-value walkthrough on EMR and its top sector peer
  • βœ“Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
EMR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +21.76%β–² ASCENDING CHANNEL
2026-11-02O $167.7H $170.7L $164.9C $164.9VOL 1.61M
RES: $171.5SUP: $153.0SMA50: $157.6SMA200: $147.3
$174.3$161.8$149.3$136.8$124.2RES $171.5SUP $153.0$164.92026-05-042026-06-172026-08-042026-09-182026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

EMR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
31.4%/yr Implied 5Y Growth

vs. +3.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on EMR today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for EMR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for EMR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EMR)

1. Head-to-Head Technology Peer Comparison (EMR vs. GEV, OTIS, GE, FXHO)

Industry: Consumer Electronics/Appliances (22 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Emerson Electric Company (EMR) ranks #105 by composite RQD confidence (69/100, grade C+) and #46 by equity capitalization ($95.24B). Within this direct 5-issuer industry benchmark cohort, OTIS leads on earnings valuation at 20.5x trailing P/E, while OTIS leads on capital efficiency and profitability with 74.2% ROIC and β€” gross margin. EMR currently leads its immediate peer cohort in composite quantitative strength at 69/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
EMR ACTIVE
Emerson Electric Company
C+ 69/100 41.5x 52.8% 9.7% -3.40% $95.24B Benchmark Subject
GEV
GE Vernova Inc.
D 49/100 48.1x 19.8% 4.4% -3.38% $234.99B /gev-vs-emr β†’
OTIS
Otis Worldwide Corporation
C 65/100 20.5x β€” 74.2% +1.53% $28.40B /otis-vs-emr β†’
GE
GE Aerospace
D+ 57/100 37.2x β€” 16.8% -3.59% $323.49B /ge-vs-emr β†’
FXHO
UTime Limited (Class A)
E 27/100 β€” 1.0% β€” -15.52% $193.1M /fxho-vs-emr β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-09-30 β€’ CIK 0000032604

In its most recent audited fiscal period (FY2025, filed 2025-09-30), Emerson Electric Company (EMR) reported GAAP revenue of $18.02B (+3.0% vs. FY2024 revenue of $17.49B , and +18.8% cumulative change since FY2023) , GAAP net income of $2.29B, operating cash flow of $3.10B, and free cash flow of $2.67B (-8.4% YoY). On the balance sheet, EMR closed FY2025 with $41.94B in total assets against $7.58B in total debt (Altman Z-Score: 4.80, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-09-30 $18.02B $2.29B $3.10B $2.67B $41.94B $7.58B
FY2024 (FY) 2024-09-30 $17.49B $1.97B $3.33B $2.91B $42.61B $6.56B
FY2023 (FY) 2023-09-30 $15.16B $13.22B $637.0M -$45.4M $52.38B $12.26B

3. EMR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is EMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Emerson Electric Company (NYSE: EMR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $164.94 (-3.40% 1D, market cap $95.24B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 18/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, EMR ranks #105 in composite RQD confidence.

How does EMR compare to GEV and OTIS in the Technology sector?

Within the Technology sector (Consumer Electronics/Appliances), EMR carries a Roarable C+ (69/100 RQD), trailing P/E of 41.5x, gross margin of 52.8%, and ROIC of 9.7%. By comparison, GEV (GE Vernova Inc.) holds a D grade (49/100 RQD, P/E 48.1x, ROIC 4.4%, cap $234.99B) and OTIS (Otis Worldwide Corporation) posts a C grade (65/100 RQD, P/E 20.5x, ROIC 74.2%, cap $28.40B). Among the 5-stock peer group, OTIS leads on earnings multiple (20.5x) while OTIS leads on capital efficiency (74.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for EMR?

Per EMR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0000032604), Emerson Electric Company generated $18.02B in revenue (+3.0% YoY), $2.29B in net income, and $2.67B in free cash flow against $41.94B in total assets and $7.58B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is EMR trading relative to its 50-day, 200-day, and 52-week technical levels?

EMR last traded at $164.94 (-3.40% on volume of 4,077,024 shares), positioning the stock +4.66% above its 50-day simple moving average ($157.60) and +12.01% above its 200-day simple moving average ($147.25). Across its 52-week range of $122.64 to $171.25, EMR sits at the 87.0% percentile with a 14-day RSI of 64.1 (BULLISH MOMENTUM) and an implied next-earnings move of Β±5.6% ($155.70 to $174.18).

EMR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Does EMR pay a dividend and is it safe?

Emerson Electric Company (EMR) offers a 1.25% cash dividend yield ($2.06 annualized) and 3.05% total shareholder yield including buybacks. Roarable rates its payout coverage as FORTRESS PAYOUT.

ROARABLE RATING BRIEF β€’ RQD 69/100 (C+) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

EMR β€” Emerson Electric Company: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:09:51Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, EMR scores 69 out of 100 (grade C+), with the verdict "Roarable Hold β€” Upper Neutral / Watch for Breakout." The five pillars are:

  • Fundamental Cash Engine: 12 / 20. Per the Roarable RQD rating, this reflects ROIC of 9.7% and an FCF yield of 2.8%. Investor implication: returns on capital are positive but not exceptional, and the cash yield is modest relative to the stock's valuation multiples.
  • Whale 13F Flow: 18 / 20. Per the Roarable RQD rating, this reflects institutional accumulation and options positioning. Investor implication: institutional demand is a notable upside driver in the rating's framework.
  • Insider Conviction: 11 / 20. Per the Roarable RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow. Investor implication: insider signals are mixed-to-moderate and do not provide a strong confirmation either way.
  • Macro Regime Fit: 10 / 20. Per the Roarable RQD rating, this reflects Beta of 1.34 and sector sensitivity. Investor implication: the stock is more volatile than the market in this framework, which increases exposure to macro swings.
  • Forensic Balance Sheet: 18 / 20. Per the Roarable RQD rating, this reflects Altman Z of 4.8, Piotroski F of 7/9, and Debt/Equity of 0.37. Investor implication: the balance sheet is a relative strength in the rating.

Valuation tradeoff: per the market data, P/E (TTM) is 41.5 and EV/EBITDA is 30.9, which are elevated multiples. Per the Roarable RQD rating, the combination of strong institutional and balance-sheet scores against weaker cash-return and macro-fit scores frames the stock as a hold with a breakout watch rather than a clear accumulation signal.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
$170.74$95.24B41.538.630.94.111.25%1.34$122.64 - $171.259.7%

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$18016.0M$2705.7M$2293.0MN/A$2667.0MN/A$7575.0M
FY 2024$17492.0M$2322.2M$1968.0MN/A$2913.0MN/A$6557.0M
FY 2023$15165.0M$15598.4M$13219.0MN/A$-45.4MN/A$12257.2M

Per the SEC financials, revenue rose from $17492.0M (FY 2024) to $18016.0M (FY 2025), and FCF declined from $2913.0M to $2667.0M over the same period. Per the market data, ROIC is 9.7%, and net margin is 12.7%. Per the Roarable RQD rating, the Altman Z-Score is 4.8 and the Piotroski F-Score is 7/9, with Debt/Equity at 0.37. The FY 2023 net income figure ($13219.0M) is shown as reported in the source and is not reconciled against the other periods here.

Open Questions

  • What are the reported EPS and cash balances for FY 2023 through FY 2025, which the financials table lists as N/A?
  • What drove the gap between FY 2023 operating income ($15598.4M) and net income ($13219.0M) versus the closer relationship in later periods?
  • What business segments and revenue sources generate EMR's income, given that the profile classifies it in Consumer Electronics/Appliances?
  • What specific institutional and options flows underlie the Whale 13F Flow pillar score of 18/20?
  • What analyst consensus, price targets, and insider trade details exist, given that analyst and holder data are absent?

EMR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Emerson Electric Company (EMR) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to EMR Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

EMR Bull vs. Bear Conversation Board β€” What's Your Call at $164.94?

πŸ‚ 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON EMR 🐻 50% BEARISH CONVICTION
1. Pick Your Side on EMR:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk βš–οΈ DEBATE HOST 🎯 Target: $184.40 (+8.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is EMR (C+ β€’ RQD 69/100) a Buy at $170.74?

Welcome to the EMR (Emerson Electric Company) Roar Pit. Current RQD Composite is 69/100 (Roarable Hold β€” Upper Neutral / Watch for Breakout) in Consumer Electronics/Appliances. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (41.5x trailing P/E). Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $141.71 (-17.0%)
Spot @ $170.74

Pump the brakes on EMR β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on EMR, but look at what you are paying: 41.5x trailing P/E with 52.8% gross margins. Unless Emerson Electric Company expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

AL AlphaFlow_Cap Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $204.89 (+20.0%)
Spot @ $170.74

EMR cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on EMR, the market is fixating on short-term headline noise in Consumer Electronics/Appliances and ignoring the balance sheet and cash flow trajectory. At $170.74 (52-wk range $122.64 - $171.25), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%